About Aaron Missere
Aaron Missere is the CEO and founder of financial media company Departures Capital Inc. He is an avid and experienced investor, with a primary focus on the cannabis industry. In addition to being a featured contributor to StockNews.com and ETFDailyNews.com, he is an author for SmarterAnalyst.com. Aaron also currently hosts a weekly show on YouTube that recaps and explains the movement in the stock market, with a heavy emphasis on marijuana stocks.
Recent Articles By Aaron Missere
Has Marijuana Stock HEXO Corp. (HEXO) Found a Bottom?
This past month HEXO has shown stability, holding onto $2 per share, and many investors are speculating that this could be the bottom.
Are Shares of Tilray (TLRY) a Buy?
This week Tilray announced that former Mattel and General Mills executive Katy Dickson has joined the companies leadership team.
What Can We Expect to Learn from Canopy Growth's (CGC) Investor Meeting?
Canopy Growth Corp., the largest cannabis company in the world by market cap, has had a few disappointing quarters recently.
2 Pieces of Good News for Aurora Cannabis (ACB)
Recently, shares of Aurora Cannabis (ACB) have had a bumpy ride but this week we saw some good news released for the company.
Are Shares of Organigram (OGI) a Buy, After Their Weak Fourth Quarter?
The recent round of earnings for the vast majority of large-cap cannabis companies in Canada has been weak.
Is the Worst Over for Shares of Aurora Cannabis (ACB)?
It's been a bumpy ride for Aurora Cannabis (ACB) shareholders over the past two weeks.
Will the rally continue for Innovative Industrial Properties (IIPR)?
Despite the challenging environment in the cannabis sector at this time, Innovative Industrial Properties (IIPR) has been bucking the trend when it comes to stock performance.
Is Cannabis Stock Aurora Cannabis (ACB) a Buy?
This week started off with the cannabis sector plunging into the red with double-digit losses for many large-cap stocks. Aurora Cannabis was among one of the biggest decliners in the market.
Canopy Growth: Sell, Buy or Hold?
To simply put it, these numbers weren’t good, and as a result shares slid 15% the day of earnings to fresh 52-week lows.